Bharat Biotech top brass calls on Vice President M Venkaiah Naidu to discuss Covaxin status

Published On 2020-12-26 06:50 GMT   |   Update On 2020-12-26 06:50 GMT
Advertisement

New Delhi: Bharat Biotech''s top brass on Friday called on Vice President M Venkaiah Naidu in Hyderabad.

"The discussion revolved around the status of the indigenous vaccine and the plans to make it available in India and rest of the world. It is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV)," an official statement said.

Advertisement

The indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech''s BSL-3 (Bio-Safety Level 3) bio-containment facility, the statement said.

Recently, Prime Minister Narendra Modi had visited Bharat Biotech''s facility and reviewed the status of Covaxin. It was followed by a visit of 70 ambassadors and high commissioners from several nations to the facility at Genome Valley, Hyderabad, it said.

Read also: AIIMS Delhi invites volunteers for Phase 3 Trial Of Bharat Biotech Covaxin

During the interaction, the vice president stressed on the importance of public-private partnership in coming out with indigenous world-class products and lauded the collaboration between the ICMR and Bharat Biotech, it said.

Read also: Bharat Biotech re-applies with DCGI for emergency approval of Covaxin



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News